Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 383

    German Merck considers sale of consumer health business

    German Merck considers sale of consumer health business

    Ruby Khatun Khatun6 Sept 2017 9:42 AM IST
    FRANKFURT/COLOGNE: Germany's Merck KGaA is considering selling its $1 billion consumer health unit to meet its financial targets as a decline in its...
    Lupin launches generic hypertension drug in US market

    Lupin launches generic hypertension drug in US market

    Ruby Khatun Khatun5 Sept 2017 10:37 AM IST
    New Delhi: Drug maker Lupin on Monday announced the launch of its Olmesartan Medoxomil tablets, a hypertension drug, in the US market.The company has...
    Teva gets FDA approval for AUSTEDO tablets to treat Tardive Dyskinesia in adults

    Teva gets FDA approval for AUSTEDO tablets to treat Tardive Dyskinesia in adults

    Ruby Khatun Khatun5 Sept 2017 10:16 AM IST
    JERUSALEM: Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved AUSTEDO®(deutetrabenazine)...
    FDA clears mammography device with option for patient-assisted compression

    FDA clears mammography device with option for patient-assisted compression

    Ruby Khatun Khatun5 Sept 2017 9:56 AM IST
    The U.S. Food and Drug Administration (FDA) cleared the first 2D digital mammography system that allows patients to increase or decrease the amount of...
    Ozone Group partners Brazils Embelleze for hair care products

    Ozone Group partners Brazils Embelleze for hair care products

    Ruby Khatun Khatun5 Sept 2017 9:21 AM IST
    New Delhi: Pharma and FMCG firm Ozone Group announced its foray into the professional hair care segment by partnering Brazil's Embelleze.Ozone Organic...
    Zydus Cadila gets USFDA nod for Mycophenolate Mofetil

    Zydus Cadila gets USFDA nod for Mycophenolate Mofetil

    Ruby Khatun Khatun4 Sept 2017 11:00 AM IST
    New Delhi: Cadila Healthcare said its group firm Zydus Cadila has received final approval from the USFDA to market Mycophenolate mofetil for injection...
    Roche Diagnostics India looks at 15 per cent IVD market share in 2 years

    Roche Diagnostics India looks at 15 per cent IVD market share in 2 years

    Ruby Khatun Khatun4 Sept 2017 10:30 AM IST
    New Delhi: Roche Diagnostics India is aiming at 15 per cent share of the in-vitro diagnostics market in the next two years as part of its growth plans...
    Jubilant Pharma completes US radio-pharmacy Triad Isotopes acquisition

    Jubilant Pharma completes US radio-pharmacy Triad Isotopes acquisition

    Ruby Khatun Khatun4 Sept 2017 10:00 AM IST
    New Delhi: Jubilant Life Sciences said its subsidiary Jubilant Pharma has completed the acquisition of the US radiopharmacy business of Triad Isotopes...
    1mg acquires Dawailelo to strengthen pharmacy operations

    1mg acquires Dawailelo to strengthen pharmacy operations

    Ruby Khatun Khatun4 Sept 2017 9:30 AM IST
    New Delhi: 1mg, India’s largest digital health platform, has announced that it has acquired Dawailelo.com, a technology-based facilitator in the...
    Nestle shuts Swiss skin health products factory

    Nestle shuts Swiss skin health products factory

    Ruby Khatun Khatun4 Sept 2017 9:15 AM IST
    ZURICH: Nestle said on Thursday it was closing a Swiss factory which makes products for its skin health business, responding to a slowdown in a...
    Abbott releases new round of cyber updates for St. Jude pacemakers

    Abbott releases new round of cyber updates for St. Jude pacemakers

    Ruby Khatun Khatun3 Sept 2017 1:37 PM IST
    NEW YORK: Abbott Laboratories said on Tuesday it would issue updates to reduce the risk of its St. Jude heart implants being hacked and to warn...
    Fitbit launches Ionic, the ultimate health and fitness smartwatch

    Fitbit launches Ionic, the ultimate health and fitness smartwatch

    Ruby Khatun Khatun3 Sept 2017 9:49 AM IST
    SAN FRANCISCO: Fitbit, the leading global wearables brand, announced its first smartwatch – Fitbit Ionic™. A health and fitness first platform, Ionic...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok